Evaluation of Supplementation of Bittergourd Fermented Beverage to Diabetic Subjects


 Bittergourd fermented beverage, diabetes, supplementation, biochemical parameters.

How to Cite

C.S. Devaki, & K.S. Premavalli. (2014). Evaluation of Supplementation of Bittergourd Fermented Beverage to Diabetic Subjects. Journal of Pharmacy and Nutrition Sciences, 4(1), 27–36. https://doi.org/10.6000/1927-5951.2014.04.01.5


Diabetes mellitus is a chronic endocrine diseased condition reflected by higher level of blood glucose which is due to less insulin production, insulin action or both. Bittergourd juice consumption is being traditionally practiced for the treatment of diabetes mellitus in developing country such as India, but not supported through clinical data and highly bitter juice is difficult to drink. Therefore bittergourd fermented beverage with improved nutritional strength and taste was developed and supplemented to diabetic subjects and the evaluation was carried out. The evaluation of the bittergourd fermented beverage, in the first stage was carried out by supplementing the beverage to 30 diabetic subjects as an early morning drink in fasting conditionand the control group was asked to drink water. The fasting and post prandial blood sugar levels were studied and diabetic symptoms were noted. The impact of supplementation of bittergourd fermented beverage on diabetic subjects showed that subjects had significant improvement in reducing the symptoms of diabetes, as well reduced the fasting and post prandial glucose levels by 31% and 25% respectively when compared with the control group. Further 16 diabetic subjects who expressed their consent were given the bittergourd fermented beverage for a period of 5 months and the results of the long duration supplementaion indicated that there was a reduction of fasting blood glucose by 43% and post prandial blood glucose by 41% reflecting advantage of continued consumption of the beverage. In order to understand the direct action of the beverage on blood lipid profile–serum cholesterol, triglycerides, low density lipoprotein cholesterol, high density lipoprotein cholesterol as measured before and after supplementation showed the changes by 4-7% which is not considerable. However the glycoslated haemoglobin indicated encouraging results after the supplementation showing good control from fair control. Therefore, the study clearly reflected the positive effect of bittergourd fermented beverage in reducing and controlling blood sugar levels.



Xie H, Huang S, Deng H, Wu Z, Ji A. Study on chemical components of Momordica charantia. Zhong Yao Cai 1998; 21: 458-459

Braca A, Siciliano T, D'Arrigo M, Germano MP. Chemical composition and antimicrobial activity of Momordica charantia seed essential oil. Fitoterapiam 2008; 79: 123-125. http://dx.doi.org/10.1016/j.fitote.2007.11.002

Zhang M, Hettiarachchy NS, Horax R, Chen P, Over KF. Effect of maturity stages and drying methods on the retention of selected nutrients and phytochemicals in bitter melon (Momordica charantia) leaf. Journal of Food Science 2009; 74: 441-448. http://dx.doi.org/10.1111/j.1750-3841.2009.01222.x

Devaki C S and Premavalli K S. Development of bittergourd fermented beverage using response surface methodology. Journal of Pharmacy and Nutrition Sciences 2012; 2 (1): 94-103.

WHO, Diabetes Programme. http://www.who.int/diabetes/ facts/world_Figs/en/2007.

Karunanayake EH, Jeevathayaparan S, Tennekoon KH. Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. Journal of Ethnopharmacology 1990; 30(2): 199-204. http://dx.doi.org/10.1016/0378-8741(90)90008-H

Day C, Cartwright T, Provost J, Bailey CJ. Hypoglycaemic effect of Momordica charantia extracts. Planta Medica 1990; 56(5): 426-9. http://dx.doi.org/10.1055/s-2006-961003

Ali L, Khan AKA, Mamun MIR, Mosihuzzaman MM, Nahar N, Nur-e-Alam M and Rokeya B. Studies on hypoglycemic effects of fruit pulp, seed, whole plant of Momordica charantia on normal and diabetic model rats. Planta Medica 1993; 59(5): 408-12. http://dx.doi.org/10.1055/s-2006-959720

Abd, El Sattar, El Batran S, El Gengaihi SE, El Shabrawy OA. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. Journal of Ethnopharmacology 2006; 108(2): 236-42. http://dx.doi.org/10.1016/j.jep.2006.05.015

Cakici I, Hurmoglu C, Tunctan B, Abacioglu N, Kanzik I, Sener B. Hypoglycaemic effect of Momordica charantia extracts in normoglycaemic or cyproheptadineinduced hyperglycaemic mice. Journal of Ethnopharmacology 1994; 44(2): 117-21. http://dx.doi.org/10.1016/0378-8741(94)90077-9

Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacological Research 1996; 33(1): 1-4. http://dx.doi.org/10.1006/phrs.1996.0001

Welihinda J, Arvidson G, Gylfe E, Hellman B, Karlsson E. The insulin-releasing activity of the tropical plant Momordica charantia. Acta Biologica et Medica Germanica 1982. 41(12): 1229-40.

Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin diabetic rat. Diabetes Research Journal on Clinical Practice 1998; 40(3): 145-51. http://dx.doi.org/10.1016/S0168-8227(98)00022-9

Sitasawad SL, Shewade Y, Bhonde R. Role of bittergourd fruit juice in streptozotocin induced diabetic state in vivo and in vitro. Journal of Ethnopharmacology 2000; 73(1-2): 719. http://dx.doi.org/10.1016/S0378-8741(00)00282-8

Anun YS, Adisakwattana S, Yao C. Slow acting protein extract from fruit pulp of mc with insulin secretagogue and insulinomimetic activities. Biological and Pharmaceutical Bulletin 2006; 29: 1126-1131. http://dx.doi.org/10.1248/bpb.29.1126

Ahmad N, Hassan MR, Halder H, Bennoor KS. Effect of Momordica charantia (Karolla) extracts on fasting and post-prandial serum glucose levels in NIDDM patients. Bangla-desh Medical Research Council Bulletin 1999; 25(1): 11-3.

Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. Journal of Ethnopharmacology 1986; 17(3): 277-82. http://dx.doi.org/10.1016/0378-8741(86)90116-9

WHO expert consultation. Appropriate body mass index for Asian Population and its complication for policy and intervention strategies. Lancet 2004; 10: 157-163.

Annapurna. Nutritive value of Foods 2003. Version 1.0.

Rao BK, Kesavulu MM, Giri R, Appa RC. Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. Fruit powder in alloxan-diabetic rats. Journal of Ethnopharma-cology 1999; 67(1): 103-9. http://dx.doi.org/10.1016/S0378-8741(99)00004-5

Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK. Antihyperglycemic effects of three extracts from Momordica charantia. Journal of Ethnopharmacology 2003; 88 (1): 107-11. http://dx.doi.org/10.1016/S0378-8741(03)00184-3

Shetty AK, Kumar GS, Sambaiah K, Salimath PV. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods for Human Nutrition 2005; 60 (3): 109-12. http://dx.doi.org/10.1007/s11130-005-6837-x

Krawinkel MB, Keding GB. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia. Nutrition Reviews 2006; 64 (7 Pt 1): 331-7.

Akhtar MS. Trial of Momordica charantia Linn (Karela) powder in patients with maturity-onset diabetes. Journal of Pakistan Medical Association 1982; 32(4): 106-7.

Zhang QC. Preliminary report on the use of Momordica charantia extract by HIV patients. Journal of Naturopathic Medicine 1992; 3: 65-9.

Matsuda H, Li Y, Murakami T, Ninomiya K, Yamahara J, Yoshikawa M. Effects of escins Ia, Ib, IIa, IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biological and Pharmaceutical Bulletin 1997; 20: 1092-1095. http://dx.doi.org/10.1248/bpb.20.1092

Platel K, Srinivasan K. Plant foods in the management of Diabetes mellitus: Vegetables as potential hypoglycaemic agents. Nahrung 1997; 41(2): 68-74. http://dx.doi.org/10.1002/food.19970410203

Matsuda H, Li Y, Murakami T, Matsumura N, Yamahara J, Yoshikawa M. Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chemical & Pharmaceutical Bulletin (Tokyo) 1998; 46(9): 1399-403. http://dx.doi.org/10.1248/cpb.46.1399

Matsuda H, Li JY, Yamahara, Yoshikawa M. Inhibition of gastric emptying by triterpene saponin, momordin Ic, in mice: Roles of blood glucose, capsaicin-sensitive sensory nerves, central nervous system. The Journal of Pharmacology and Experimental Therapeutics 1999; 289(2): 729-34.

Raza H, Ahmed I, John A, Sharma AK. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. The Journal of Biochemical and Molecular Toxicology 2000; 14(3): 131-9. http://dx.doi.org/10.1002/(SICI)1099-0461(2000)14:3<131::AID-JBT2>3.0.CO;2-Q

Ramachandran A. Epidemiology of type 2 diabetes in Indians. Journal of Indian Medical Association 2002; 100: 425-427.

ICMR, Dietary Guidelines. 1998. A manual, National Institute of Nutrition, Hyderabad.

Sridhar MG, Vinayagamoorthi R, Arul SV, Bobby Z, Selvaraj N. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. British Journal of Nutrition 2008; 99 (4): 806. http://dx.doi.org/10.1017/S000711450783176X

Gmanews. 2007. http://www.gmanews.tv/story/35962/ Ampalaya-tablets-out-soon-for-diabetics

Baky A, Abdulla HA, Mawgoud, A, Effat A, Hay E. Hypogl-ycemic and hypolipidaemic action of bitter melon on normo-glycemic and hyperglycemic diabetic rats. Research Journal of Medicine and Medical Science 2009; 4(2): 519-525.

Ahmed I, Lakhani MS, Gillett M, John A, Raza H. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin induced diabetic rats. Diabetes Research Journal on Clinical Practice 2001; 51(3): 155-61. http://dx.doi.org/10.1016/S0168-8227(00)00224-2

Chaturvedi P, George S, Milinganyo M, Tripathi YB. Effect of Momardia charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytotherapy Research 2004; 18: 954-956. http://dx.doi.org/10.1002/ptr.1589

Chaturvedi, P. Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet, British Journal of Biomedical Science 2005; 62(3): 124-6.

Jayasooriya AP, Sakono M, Yukizaki C, Kawano M, Yamamoto K, Fukuda N. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol enriched diets. Journal of Ethnopharmacology 2000; 72(1-2): 331-336. http://dx.doi.org/10.1016/S0378-8741(00)00259-2

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2014 C.S. Devaki , K.S. Premavalli